Literature DB >> 22682541

The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone.

Margriet G A Sattler1, André P van Beek, Bruce H R Wolffenbuttel, Gerrit van den Berg, Wim J Sluiter, Johannes A Langendijk, Alphons C M van den Bergh.   

Abstract

BACKGROUND AND
PURPOSE: To assess and compare the incidence of intra- and extracranial tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy and surgery alone. PATIENTS AND METHODS: A total of 462 pituitary adenoma patients were treated between 1959 and 2008 at the University Medical Center Groningen in The Netherlands. Postoperative radiotherapy was administered on indication in 236 patients.
RESULTS: The median follow-up time was 14 (range 1-49) years in patients treated with radiotherapy and 6 (range 1-34) years in patients treated with surgery alone. Three radiotherapy patients developed an intracranial tumour compared to one patient treated with surgery alone. The numbers of extracranial tumours per follow-up year were 6.5 (95% CI 2.5-10.5) and 5.1 (95% CI 1.9-8.2) in patients treated with and without a technique with vertex field and central body axis irradiation and 7.1 (CI 95% 2.9-11.2) in surgery alone patients. Forty-five patients treated with radiotherapy died compared to twenty-four patients treated with surgery alone (log-rank test RR 1.26, 95% CI 0.77-2.08, p=0.36).
CONCLUSION: In this study postoperative radiotherapy and a radiotherapy treatment technique with vertex field and central body axis irradiation were not associated with an increased incidence of second tumours and mortality in pituitary adenoma patients.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22682541     DOI: 10.1016/j.radonc.2012.04.024

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

Review 1.  Updates in outcomes of stereotactic radiation therapy in acromegaly.

Authors:  Monica Livia Gheorghiu
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study.

Authors:  Paul D Brown; Miran Blanchard; Krishan Jethwa; Kelly D Flemming; Cerise A Brown; Robert W Kline; Debra J Jacobson; Jennifer St Sauver; Bruce E Pollock; Yolanda I Garces; Scott L Stafford; Michael J Link; Dana Erickson; Robert L Foote; Nadia N I Laack
Journal:  Neurooncol Pract       Date:  2014-03

3.  Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas.

Authors:  Beatriz Lecumberri; Javier Estrada; José García-Uría; Isabel Millán; Luis Felipe Pallardo; Luis Caballero; Tomás Lucas
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

4.  Pituitary neuroendocrine tumors and differentiated thyroid cancer: do metabolic and inflammatory risk factors play roles?

Authors:  G Cortês Nascimento; A G P de Araujo Cortês Nascimento; C de Maria Ribeiro Veiga Parente; V P Rodrigues; R S de Sousa Azulay; V C de Carvalho Rocha; S da Silva Pereira Damianse; M Magalhães; M Dos Santos Faria; M B Gomes
Journal:  J Endocrinol Invest       Date:  2020-07-17       Impact factor: 4.256

5.  A permissive role of growth hormone (GH) in the development of second brain tumors after radiotherapy?

Authors:  Pia Burman; Olaf M Dekkers
Journal:  Endocrine       Date:  2017-05-18       Impact factor: 3.633

Review 6.  Cushing's syndrome in childhood: update on genetics, treatment, and outcomes.

Authors:  Maya Lodish
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-02       Impact factor: 3.243

Review 7.  Pituitary disease mortality: is it fiction?

Authors:  Eva Marie Erfurth; Peter Siesjö; Thomas Björk-Eriksson
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

Review 8.  STEREOTACTIC RADIATION THERAPY IN PITUITARY ADENOMAS, IS IT BETTER THAN CONVENTIONAL RADIATION THERAPY?

Authors:  M L Gheorghiu; M Fleseriu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

Review 9.  Recent advances in the management of acromegaly.

Authors:  Georgia Ntali; Niki Karavitaki
Journal:  F1000Res       Date:  2015-12-11

Review 10.  Current therapies and mortality in acromegaly.

Authors:  S Găloiu; C Poiană
Journal:  J Med Life       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.